Richard Waines from DCVC Bio

Richard Waines is an Investor at DCVC Bio. DCVC Bio invests in early-stage, deep-tech life science companies that are leveraging computational approaches, including AI and automation, to transform existing technologies and accelerate the development of new ones. Chapters/Takeaways 03:19 → Journey into Biotech Investing 11:53 → DCVC Bio's Focus and Investment Strategy 16:19 → Exploring Platform Therapeutics in Biotech 20:15 → Nuances of Biotech Investing vs. Other Industries 23:11 → Managing Science Risk in Biotech Investments 27:58 → Key Personnel Changes During Company Growth 30:24 → Geographical Considerations in Biotech Investments 34:30 → The Passion for Science vs. Business in Biotech 36:08 → The Role of an Associate in Venture Capital 41:17 → The Impact of AI on Biotech Investments